Masters C L, Simms G, Weinman N A, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome [J]. Proc Natl Acad Sci USA, 1985, 82(12): 4245-4248.
[1]
Chao C P, Kotsenas A L, Broderick D F. Cerebrai amyloid angiopathy: CT and MR imaging findings[J].Radiographics, 2006, 26(5): 1517-1531.
[8]
McCarron M O, Nicoll J A, Love S, et al. Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy 2 related haemorrhage [J]. Br J Neurosurg, 1999, 13: 462-465.
[2]
Rovelet-Lecrux A, Hannequin D, Raux,G. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy [J]. Nat Genet, 2006, 38: 24-26.
[9]
Maat-Schieman M, Roos R, Van Duinen S. Hereditary cerebral hemorrhage with amyloidosis-Dutch type[J]. Neuropathology, 2005, 25(4): 288-297.
Attems J. Sporadic cerebral amyloid angiopathy: pathology,clinical implications, and possible pathomechanisms [J]. Acta Neuropathol(Berl), 2005, 110(4): 345-359.
[4]
De Leon M J, George A E, Stylopoulos L A, et al. Early marker for Alzheimer’s disease: the atrophic hippocampus [J]. Lancet, 1989, II(8664): 672-673.
[11]
Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy [J]. Ann Neurol, 2005, 58(3): 459-462.
[5]
Jobst K A, Smith A D, Barker C S, et al. Association of atrophy of medial temporal lobe with reduced blood flow in patients with a clinical and pathological diagnosis of Alzheimer’s disease [J]. J Neurol Neurosury Psychiatry, 1992, 55: 190-196.
[12]
Izumihara A, Suzuki M, Ishihara T. Recurrence and extension of lobar hemorrhage related to cerebral amyloid ngilpathy:multivariate analysis of clinical risk factors[J]. Surg Neurol, 2005, 64(2): 160-164.
Masters C L, Simms G, Weinman N A, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome [J]. Proc Natl Acad Sci USA, 1985, 82(12): 4245-4248.
[13]
Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain Aβ by neprilysin[J]. Scienc, 2001, 292: 1550-1552.
[8]
McCarron M O, Nicoll J A, Love S, et al. Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy 2 related haemorrhage [J]. Br J Neurosurg, 1999, 13: 462-465.
[14]
Mouri A, Zou L B, Iwata N, et al. Inhibition of neprilysin by thiorphan (i.c.v) causes an accumulation of amyloid and impairment of learning and memory[J]. Behav Br Res, 2006, 168: 83-91.
[15]
Iwata N, Takaki Y, Fukami S, et al. Region-specific reduction of A β degrading endopeptidase, neprilysin, in mouse hippocampus upon aging[J]. J Neurosci Res, 2002,70: 493-500.
[9]
Maat-Schieman M, Roos R, Van Duinen S. Hereditary cerebral hemorrhage with amyloidosis-Dutch type[J]. Neuropathology, 2005, 25(4): 288-297.
[10]
Attems J. Sporadic cerebral amyloid angiopathy: pathology,clinical implications, and possible pathomechanisms [J]. Acta Neuropathol(Berl), 2005, 110(4): 345-359.
[16]
Nobuhisa I, Tsubuki S. Identification of the major Aβ 1-42-degrading catabolic pathway in brain parenchyma: Su-ppression leads to biochemical and pathological deposition [J]. Natrue Med, 2000, 6: 143-150.
[11]
Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy [J]. Ann Neurol, 2005, 58(3): 459-462.
[17]
Nobuhisa I, Mizukami H, Sirotani K, et al. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid -β peptide in mouse brain [J]. J Neurosci, 2004, 24(4): 991-998.
[12]
Izumihara A, Suzuki M, Ishihara T. Recurrence and extension of lobar hemorrhage related to cerebral amyloid ngilpathy:multivariate analysis of clinical risk factors[J]. Surg Neurol, 2005, 64(2): 160-164.
Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain Aβ by neprilysin[J]. Scienc, 2001, 292: 1550-1552.
[14]
Mouri A, Zou L B, Iwata N, et al. Inhibition of neprilysin by thiorphan (i.c.v) causes an accumulation of amyloid and impairment of learning and memory[J]. Behav Br Res, 2006, 168: 83-91.
Iwata N, Takaki Y, Fukami S, et al. Region-specific reduction of A β degrading endopeptidase, neprilysin, in mouse hippocampus upon aging[J]. J Neurosci Res, 2002,70: 493-500.
[21]
Huang J, Guan H, Booze R M, et al. Estrogen regulates neprilysin activity in rat brain [J]. Neurosci Lett, 2004, 367(1): 85-87.
[16]
Nobuhisa I, Tsubuki S. Identification of the major Aβ 1-42-degrading catabolic pathway in brain parenchyma: Su-ppression leads to biochemical and pathological deposition [J]. Natrue Med, 2000, 6: 143-150.
[22]
Shirotani K, Tsubuki S, Iwata N, et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidlyand drriciently among thiorphan-and phosphoramidon-sensitive endopeptidases[J]. J Biol Chem, 2001, 276(24): 21895-21901.
[17]
Nobuhisa I, Mizukami H, Sirotani K, et al. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid -β peptide in mouse brain [J]. J Neurosci, 2004, 24(4): 991-998.
[23]
Marr R A, Rockenstein E, Mukherjee A, et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice[J]. J Neurosci, 2003, 23(6): 1992-1996.
Tian J, Shi J, Bailey K, et al. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer’s disease [J]. Neuropathol Appl Neurobiol, 2004, 30(1): 46-56.
Hauss-Wegrzyniak B, Wenk G L. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle [J]. Neurosci Lett, 2002, 322(2): 75-78.
Huang J, Guan H, Booze R M, et al. Estrogen regulates neprilysin activity in rat brain [J]. Neurosci Lett, 2004, 367(1): 85-87.
[22]
Shirotani K, Tsubuki S, Iwata N, et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidlyand drriciently among thiorphan-and phosphoramidon-sensitive endopeptidases[J]. J Biol Chem, 2001, 276(24): 21895-21901.
[23]
Marr R A, Rockenstein E, Mukherjee A, et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice[J]. J Neurosci, 2003, 23(6): 1992-1996.
[24]
Tian J, Shi J, Bailey K, et al. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer’s disease [J]. Neuropathol Appl Neurobiol, 2004, 30(1): 46-56.
[25]
Hauss-Wegrzyniak B, Wenk G L. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle [J]. Neurosci Lett, 2002, 322(2): 75-78.
2013, Vol. 24 
